while in the promptly evolving area of oncology investigate, correct and productive mutation screening is vital for building qualified therapies. The KRAS solutions Platform performs a pivotal purpose In this particular landscape by providing detailed solutions for KRAS mutation profiling and analysis. KRAS mutations, found in approximately 95% of